Verax gets CE Mark clearance for platelet test

09/30/2008 | Pharmaceutical Business Review Online

Verax Biomedical has obtained European clearance for its Platelet PGD test, which is designed to rapidly spot bacterial contaminants in blood cells and tissue. The device, which has also secured 510(k) clearance from the FDA, could be used to boost the safety of the blood supply, the company said.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL